Analytische Daten von Brotizolam (Lendormin) und seinen Hauptmetaboliten

  • H. Schütz
  • W.-R. Schneider

Zusammenfassung

1985 wurde mit Brotizolam (Lendormin) ein neues Thieno-traizolo-l,4-benzodiazepin eingeführt, das die von Benzodiazepinen her bekannten pharmakologischen Eigenschaften besitzt (anxiolytische, antikonvulsive, muskelrelaxierende und hypnotische Komponenten im Wirkungsspektrum). Von anderen Benzodiazepinen unterscheidet es sich nach Angaben des Herstellers (Fa. Boehringer, Ingelheim) durch eine ausgeprägte hypnogene Wirksamkeit bei niedriger Dosierung (Boehringer Ingelheim 1985).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bechtel WD (1983) Pharmacokinetics and metabolism of brotizolam in humans. Br J Clin Pharmacol [Suppl 2] 16: 279–283Google Scholar
  2. Bechtel WD (1984) Radioreceptor assay of brotizolam in human plasma. Fresenius Z Anal Chem 317: 714–715CrossRefGoogle Scholar
  3. Bechtel WD, Weber KH (1985) Brotizolam radioimmunoassay: Development, evaluation, andapplication to human plasma samples. J Pharm Sci 74: 1265–1269PubMedCrossRefGoogle Scholar
  4. Bechtel WD, Ensinger HA, Mierau J (im Druck a) Biochemical studies with brotizolam, a new triazolo-thieno-diazepine. ArzneimittelforschGoogle Scholar
  5. Bechtel WD, Mierau J, Brandt K, Förster HJ, Pook KH (im Druck b) Metabolic fate of [14CJ-brotizolam (WE 941) in the rat, dog, monkey and man. ArzneimittelforschGoogle Scholar
  6. Bechtel WD, Mierau J, Richter I, Stiasni M (im Druck c) Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam (WE 941), a new hypnotic, in the rat, dog, and rhesus monkey. ArzneimittelforschGoogle Scholar
  7. Bechtel WD, Wayjen RGA van, Ende A van den (im Druck d) Blood level, excretion, and metabolite pattern of [14C]-brotizolam (WE 941) in humans. ArzneimittelforschGoogle Scholar
  8. Boehringer Ingelheim (1985) Lendormin - Schlaftherapeutikum. Boehringer, Ingelheim (Wiss. Informationsschrift )Google Scholar
  9. Bun H, Ba BB, Coassolo P, Aubert C, Cano JP (1983) Simultaneous determination of brotizolam and its main hydroxymetabolite in plasma by capillary gas chromatography with double internal standardisation. Anal Lett 16: 327–341CrossRefGoogle Scholar
  10. Evers J, Renner E, Bechtel WD (1983) Pharmacokinetics of brotizolam in renal failure. Br J Clin Pharmacol [Suppl 2] 16: 309–313Google Scholar
  11. Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI (1983a) Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 8: 233–252PubMedCrossRefGoogle Scholar
  12. Greenblatt DJ, Locniskar A, Shader RI (1983b) Pilot pharmacokinetic study of brotizolam, a thienodiazepine hypnotic using electron capture gas liquid chromatography. Sleep 6: 72–76PubMedGoogle Scholar
  13. Jochemsen R, Rijn PA van, Hazelzet TGM, Breimer DD (1983a) Assay of midazolam, brotizolam and loprazolam in plasma by a gas chromatography and a radio-receptor technique. Clinical pharmacokinetics of benzodiazepine hypnotics. Pröfschrift, Jochemsen, R,’s-Gravenhabe, JH, Pasmans BV, pp. 66–77 (1983) P85 - 0627Google Scholar
  14. Jochemsen R, Rijn PA van, Hazelzet TGM, Breimer DD (1983b) Assay of midazolam and brotizolam in plasma by a gas chromatographic and a radio-receptor technique. Pharm Weekbl [Sci] 5: 308–312Google Scholar
  15. Jochemsen R, Wesselman JGJ, Hermans J, Boxtel CJ van, Breimer DD (1983a) Pharmacokinetics of brotizolam in healthy subjects following i.v. and oral administration. Br J Clin Pharmacol [Suppl 2] 16: 285–290Google Scholar
  16. Jochemsen R, Wesselman JGJ, Boxtel CJ van, Hermans J, Breimer DD (1983d) Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects. Br J Clin Pharmacol [Suppl 2] 16: 291–297Google Scholar
  17. Schütz H (1982) Benzodiazepines — A handbook. 156 figures, XII, 439 pages. Springer Berlin Heidelberg New York TokyoGoogle Scholar
  18. Schütz H (1986) Dünnschicht-chromatographische Suchanalyse für 1,4-Benzodiazepine in Harn, Blut und Mageninhalt. VCH-Verlagsgesellschaft, Weinheim (Mitteilung VI der Senatskommission für Klinisch-toxikologische Analytik der DFG )Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • H. Schütz
  • W.-R. Schneider

There are no affiliations available

Personalised recommendations